AstraZeneca COVID-19 vaccine trial back on track in US; Johnson & Johnson to follow

AstraZeneca COVID-19 vaccine trial back on track in US; Johnson & Johnson to follow

DNA

Published

AstraZeneca Plc has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.

Full Article